60925-61-3

Basic information

• Product Name: Ceforanide
• Synonyms: CEFORANIDE (200 MG);Ceforanide;(6R,7R)-7-[[2-[2-(Aminomethyl)phenyl]acetyl]amino]-3-[[1-(carboxymethyl)tetrazol-5-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;(6R,7R)-7α-[[(2-Aminomethylphenyl)acetyl]amino]-3-[[[1-(carboxymethyl)-1H-tetrazol-5-yl]thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;Antibiotic BL-S-786;BL-S-786;C06884;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,7-[[2-[2-(aMinoMethyl)phenyl]acetyl]aMino]-3-[[[1-(carboxyMethyl)-1H-tetrazol-5-yl]thio]Methyl]-8-oxo-,(6R,7R)-
• CAS NO: 60925-61-3
• Molecular Formula: C₂₀H₂₁N₇O₆S₂
• Molecular Weight: 519.55
• Product Categories: Ceforanide
• Mol File: 60925-61-3.mol
• Article Data: 2

Chemical Properties

• Melting Point: >150° (dec)
• Appearance: /
• Density: 1.79 g/cm³
• Refractive Index: 1.829
• Storage Temp.: Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
• Solubility: Aqueous Base (Slightly), DMSO (Slightly, Heated), Methanol (Slightly)
• PKA: 2.52±0.10(Predicted)
• Stability: Hygroscopic
• CAS DataBase Reference: Ceforanide(CAS DataBase Reference)
• NIST Chemistry Reference: Ceforanide(60925-61-3)
• EPA Substance Registry System: Ceforanide(60925-61-3)

Safety Data

• Hazardous Substances Data: 60925-61-3(Hazardous Substances Data)

Usage

Description

Ceforanide is a second generation cephalosporin with good β-lactamase resistance. It has a serum half-life of about three hours, allowing twice-daily dosing.

Originator

Bristol (USA)

Uses

Different sources of media describe the Uses of 60925-61-3 differently. You can refer to the following data:
1. Ceforanide is a cephalosporin based antibiotic used in the sterilization in various medical procedures.
2. Cephalosporin antibiotic

Definition

ChEBI: A second-generation cephalosporin antibiotic with {[1-(carboxymethyl)-1H-tetrazol-5-yl]sulfanyl}methyl and 2-(aminomethyl)phenylacetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is effective against many col forms, including Escherichia coli, Klebsiella, Enterobacter and Proteus, and most strains of Salmonella, Shigella, Hemophilus, Citrobacter and Ari ona species.

Brand name

Precef (Apothecon).

Antimicrobial activity

A semisynthetic parenteral cephalosporin with activity broadly similar to that of cefalotin. Its activity in vitro is significantly reduced in the presence of serum. A 1 g intravenous dose achieves a concentration of c. 135 mg/L at the end of infusion. The response after 0.25, 0.5 and 1 g intravenous doses is essentially linear. A 1 g intramuscular dose produces mean peak values of around 70 mg/L. Plasma protein binding is around 85%. It is almost entirely eliminated in the urine with a halflife of about 2.5 h, 80–95% being recovered in the first 12 h. The half-life is inversely related to renal function, rising to around 20 h when the creatinine clearance falls below 5 mL/min. About half the dose is removed by hemodialysis over 6 h. It is generally well tolerated; phlebitis and pain at the site of injection are reported in some patients with occasional transient neutropenia and increased transaminase levels. It has been used principally for the treatment of infections due to Gram-positive cocci, including staphylococcal and streptococcal soft-tissue infections, but is no longer widely available.

InChI:InChI=1/C20H21N7O6S2/c21-6-11-4-2-1-3-10(11)5-13(28)22-15-17(31)27-16(19(32)33)12(8-34-18(15)27)9-35-20-23-24-25-26(20)7-14(29)30/h1-4,15,18H,5-9,21H2,(H,22,28)(H,29,30)(H,32,33)/t15-,18-/m1/s1

Upstream product

• 957-68-6 7-Aminocephalosporanic acid 
• 59118-46-6 3-<<<1H-1-(carboxymethyl)tetrazol-5-yl>thio>methyl>cephem 

Relevant articles and documents

IMPROVED PROCESS FOR THE PREPARATION OF CEFORANIDE IN PURE FORM

The present invention provides an improved process for the preparation of the compound of formula (I) in pure form.